Total Payments
$10,030
2024 Payments
$1,141
Companies
55
Transactions
698
Medicare Patients
5,894
Medicare Billing
$439,865
Payment Breakdown by Category
Food & Beverage$9,917 (98.9%)
Education$113.52 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,917 | 692 | 98.9% |
| Education | $113.52 | 6 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,244 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,002 | 76 | $0 (2024) |
| Lilly USA, LLC | $897.83 | 67 | $0 (2024) |
| Novo Nordisk Inc | $814.87 | 58 | $0 (2024) |
| PFIZER INC. | $685.02 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $653.39 | 39 | $0 (2024) |
| ABBVIE INC. | $609.84 | 34 | $0 (2024) |
| Amgen Inc. | $605.96 | 39 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $491.00 | 38 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $378.69 | 34 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,141 | 60 | AstraZeneca Pharmaceuticals LP ($299.68) |
| 2023 | $1,483 | 89 | AstraZeneca Pharmaceuticals LP ($198.60) |
| 2022 | $1,246 | 86 | ABBVIE INC. ($170.35) |
| 2021 | $541.96 | 35 | AbbVie Inc. ($149.65) |
| 2020 | $366.60 | 27 | Novo Nordisk Inc ($77.47) |
| 2019 | $1,431 | 107 | PFIZER INC. ($221.25) |
| 2018 | $1,860 | 131 | Novo Nordisk Inc ($235.47) |
| 2017 | $1,960 | 163 | Novo Nordisk Inc ($240.45) |
All Payment Transactions
698 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: VACCINE | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Biological | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.58 | General |
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.67 | General |
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Biological | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Endocrinology | ||||||
| 07/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Diabetes | ||||||
| 07/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: PAIN | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Endocrinology | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,360 | 2,583 | $484,566 | $91,826 |
| 2022 | 24 | 1,361 | 3,666 | $321,027 | $106,140 |
| 2021 | 18 | 1,671 | 3,236 | $321,716 | $126,658 |
| 2020 | 23 | 1,502 | 3,165 | $339,507 | $115,242 |
Total Patients
5,894
Total Services
12,650
Medicare Billing
$439,865
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 440 | 1,102 | $278,806 | $39,781 | 14.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 227 | 227 | $75,137 | $11,983 | 15.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $13,936 | $9,297 | 66.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 99 | 99 | $8,634 | $7,069 | 81.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 151 | $27,029 | $4,812 | 17.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $22,533 | $4,260 | 18.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 104 | 104 | $7,384 | $3,094 | 41.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 34 | 35 | $14,245 | $2,000 | 14.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 55 | $4,200 | $1,951 | 46.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 26 | $9,282 | $1,284 | 13.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $2,911 | $1,220 | 41.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $6,039 | $1,149 | 19.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 86 | $4,050 | $783.95 | 19.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 17 | $2,210 | $696.66 | 31.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 14 | 83 | $2,324 | $605.68 | 26.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 11 | 11 | $931.00 | $553.08 | 59.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 18 | $1,494 | $449.14 | 30.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 89 | $979.00 | $373.80 | 38.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 27 | $756.00 | $257.04 | 34.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 281 | $1,686 | $206.89 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 426 | 1,051 | $184,983 | $47,796 | 25.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 960 | $23,040 | $16,154 | 70.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 238 | $27,393 | $9,361 | 34.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 121 | 122 | $5,734 | $5,627 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 131 | 132 | $6,572 | $3,779 | 57.5% |
About Dr. Michael Raybould, MD
Dr. Michael Raybould, MD is a Internal Medicine healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083686273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Raybould, MD has received a total of $10,030 in payments from pharmaceutical and medical device companies, with $1,141 received in 2024. These payments were reported across 698 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($9,917).
As a Medicare-enrolled provider, Raybould has provided services to 5,894 Medicare beneficiaries, totaling 12,650 services with total Medicare billing of $439,865. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location North Kansas City, MO
- Active Since 02/02/2006
- Last Updated 10/24/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083686273
Products in Payments
- FARXIGA (Drug) $896.99
- JARDIANCE (Drug) $551.11
- Victoza (Drug) $419.02
- XARELTO (Drug) $331.70
- TRULICITY (Drug) $327.56
- STIOLTO RESPIMAT (Drug) $323.29
- BREZTRI (Drug) $266.30
- CHANTIX (Drug) $261.84
- TOUJEO (Drug) $259.83
- MOUNJARO (Drug) $240.63
- SHINGRIX (Biological) $236.45
- UBRELVY (Drug) $224.27
- ELIQUIS (Drug) $219.25
- ENTRESTO (Drug) $214.36
- Ozempic (Drug) $201.40
- QULIPTA (Drug) $201.17
- Prolia (Biological) $180.00
- MYRBETRIQ (Drug) $171.35
- TRELEGY ELLIPTA (Drug) $166.20
- Otezla (Drug) $161.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Kansas City
Mahmoud Elsayed, M.d, M.D
Internal Medicine — Payments: $59,590
Internal Medicine $59,590
Crystal Lagalle, D.o, D.O
Internal Medicine — Payments: $7,717
Internal Medicine $7,717
Dr. Ethan Hacker, Md, MD
Internal Medicine — Payments: $5,485
Internal Medicine $5,485
Dr. Samin Akhtar, Md, MD
Internal Medicine — Payments: $5,340
Internal Medicine $5,340
Heath Wilt, Do, DO
Internal Medicine — Payments: $4,521
Internal Medicine $4,521
Dr. Roman Enriquez, Md, MD
Internal Medicine — Payments: $3,570
Internal Medicine $3,570